Esokalli Slimming microcrystalline patch

Manufacturer
Guangzhou Yixin Cross-border E-commerce Co., Ltd.
Effective date
2025-09-01
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 01:12:18

Label at a glance#

ProductEsokalli Slimming microcrystalline patch
Active ingredientRETATRUTIDE
Label structure11 sections

Indications and uses

To support weight management To improve glycemic control in adults with type 2 diabetes mellitus Provides long-acting sustained-release delivery via soluble microneedle patch

Dosage and administration

• Apply one transdermal patch containing 20 mg Retatrutide to the wrist or the back of the hand. • Leave the patch in place for 30 to 60 minutes, then remove. • Administer once every 3 to 7 days. • Do not reuse a patch. • Use only as directed.

Label contents#

Full prescribing information#

Active ingredient (in each patch)

COMPONENTS

Retatrutide 20 mg ……………………………. Weight management / blood sugar control

Purpose

OTC - PURPOSE SECTION

Weight loss aid
Improves blood sugar control (when used with diet and exercise)

Uses

INDICATIONS & USAGE SECTION

To support weight management
To improve glycemic control in adults with type 2 diabetes mellitus
Provides long-acting sustained-release delivery via soluble microneedle patch

Warnings

WARNINGS SECTION

For external use only

Dosage and administration

DOSAGE & ADMINISTRATION SECTION

• Apply one transdermal patch containing 20 mg Retatrutide to the wrist or the back of the hand.
• Leave the patch in place for 30 to 60 minutes, then remove.
• Administer once every 3 to 7 days.
• Do not reuse a patch.
• Use only as directed.

Do not use if you

OTC - DO NOT USE SECTION

• have type 1 diabetes

• need treatment for diabetic ketoacidosis

• are pregnant or breastfeeding

• are under 18 years of age

• have severe heart disease

• have skin disease or broken skin at the application site

• have a history of hypoglycemia

• are allergic to any ingredient in this product

When using this product

OTC - WHEN USING SECTION

• monitor blood glucose regularly

• possible side effects include:

– hypoglycemia

– nausea, vomiting, or diarrhea

– acute pancreatitis

– complications of diabetic retinopathy

– increased heart rate

– hypersensitivity or allergic reactions

Stop use and ask a doctor if

OTC - STOP USE SECTION

• you develop severe abdominal pain (possible acute pancreatitis)

• symptoms of hypersensitivity occur (rash, swelling, difficulty breathing)

• persistent gastrointestinal problems occur

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental ingestion, get medical help or contact a Poison Control Center right away.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Microcrystalline matrix, soluble microneedle polymer blend, stabilizers, adhesive layer.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11223344

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84778-082-01Esokalli Slimming microcrystalline patch20 mg in 1 PATCHPATCH203
84778-082-01Esokalli Slimming microcrystalline patch1 in 1 BOXPATCH13
84778-082-02Esokalli Slimming microcrystalline patch20 mg in 1 PATCHPATCH203
84778-082-02Esokalli Slimming microcrystalline patch2 in 1 BOXPATCH23
84778-082-03Esokalli Slimming microcrystalline patch20 mg in 1 PATCHPATCH203
84778-082-03Esokalli Slimming microcrystalline patch4 in 1 BOXPATCH43
84778-082-04Esokalli Slimming microcrystalline patch8 in 1 BOXPATCH83
84778-082-04Esokalli Slimming microcrystalline patch20 mg in 1 PATCHPATCH203

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84778-08284778-082-01, 84778-082-02, 84778-082-03, 84778-082-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3dbbfe4e-f9c5-67c8-e063-6294a90a46443d7026b8-d2cb-f4ab-e063-6294a90aeedd2025-09-01WarningsExact identifier
spl id: 3dbbfe4e-f9c5-67c8-e063-6294a90a4644
spl set id: 3d7026b8-d2cb-f4ab-e063-6294a90aeedd

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.